Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer (NCT07122687) | Innovent Biologics (Suzhou) Co. Ltd. | 2025-08-26 |
Track Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.